Advanced Avatar Dendritic Cells
AssigneeImmunityBio, Inc.
InventorPatrick Soon-Shiong
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunityBio, Inc.
InventorPatrick Soon-Shiong
Estimating the term…
Compositions, methods, and uses of recombinant immunoglobulin proteins, recombinant immunoglobulin protein complexes, carrier protein complexes, and a pharmaceutical composition including one or more of those to increase immune therapy effectiveness are presented. Preferred protein and protein complex comprise one or more functional moieties that includes a binding motif to a tumor-associated antigen, a T-cell activating molecule, and a chemokine. In some embodiments, the pharmaceutical composition includes two or more protein complexes, which are functionally distinct from each other. In other embodiments, the pharmaceutical composition includes a genetically-engineered microorganism including a first tumor-associated antigen and a T-cell activating molecule, a recombinant immunoglobulin protein complex, and a chemokine.
A recombinant immunoglobulin protein complex, comprising:
Dependencies are inferred from the claim text.